The Commission, with the Australian Digital Health Agency and the Australian Government Department of Health, has developed guidelines to standardise the presentation of on-screen medicines information. The aim was to ensure benefit from investments in e-health initiatives and to maximise patient safety.
Found 781 result(s)
Digital health systems such as electronic medication management (EMM) can improve the safety and quality of health care.
By using EMM, healthcare services can reduce the number of preventable adverse medication events, and medication prescribing and dispensing errors. EMM systems can improve the accuracy, visibility and legibility of medical information, so that the communication between professionals and consumers is clearer.
Medication errors are one of the most reported clinical incidents in acute health care settings and, while rates of serious harm are low, their prevalence is of concern particularly as many are preventable. A recognised major cause of medication errors is the use of potentially dangerous abbreviations and dose expressions.
The resources and tools listed on this page can help healthcare services implement the Labelling Standard.
Labelling resources are available for medicines and fluids in: closed-and open-practice perioperative areas; interventional cardiac catheter and radiology laboratories and in dedicated continuous infusions in all areas, including intensive care units.
The NIMC and PBS HMC are not intended for recording nutritional supplements.
The national inpatient medication chart (NIMC) and Pharmaceutical Benefits Scheme (PBS) hospital medication chart (HMC) are designed so that a single adverse drug reaction (ADR) alert sticker can be applied on both pages 3 and 4.
The National Standard Medication Chart (NSMC) audit aims to improve the safety and quality of medication charting in Australian hospitals who use paper-based NSMCs. Audit data can help health service organisations evaluate the effectiveness of NSMC safety features. These features can contribute to improved health outcomes for patients and identify areas for continuous quality improvement within hospitals.
These guidelines provide detailed guidance on the scope of changes to the national inpatient medication charts (NIMC) that can be authorised at local levels (such as state and territory, private health service chain or local hospital network, and individual health service organisation).
Some medicines – such as clozapine and subcutaneous insulin – require specialised chart features.
The NIMC and Pharmaceutical Benefits Scheme hospital medication chart (PBS HMC) include a section on VTE prophylaxis. The National Inpatient Medication Chart (NIMC) (day surgery) incorporates a modified VTE prophylaxis section.
The NIMC reduces the risk of prescribing, dispensing and administration error through standardised presentation of medicines information for an individual patient. It also standardises the way medicines information is presented in all high-risk healthcare settings.
The Commission developed the National Inpatient Medication Chart (NIMC) for clozapine titration to support the prescribing, monitoring and administration of clozapine titration.
The Commission produced the Pharmaceutical Benefits Scheme hospital medication chart (PBS HMC) to support the prescribing, administration claiming and supply of PBS and non-PBS medicines directly from the chart without the need for a separate paper prescription in hospital settings.
Private hospitals have separate documentation requirements for Medicare Australia and for pharmacy ordering, and face particular challenges because of this.
This is a two-sided A4 medication chart with no regular medicine order spaces.
Paediatric NIMC resources come in public and private hospital versions for acute and long stay.